Acupuncture for Swallowing Difficulty After a Stroke
Tests acupuncture in adults who have trouble swallowing after a stroke.
Plain-language title generated from the registry record
Registry title: Acupuncture for Post-Stroke Dysphagia: A Clinical Study
Key facts
- Where
- Tianjin, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 80 who have swallowing problems after a stroke. The stroke must have happened within the last year.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Stroke (ischemic or hemorrhagic) confirmed by CT or MRI, with disease duration within one year. Swallowing problems with FOIS grade 2-4.
- Earlier treatment
- People who received acupuncture within the past week cannot join.
Main reasons for not taking part
- Swallowing problems caused by other nerve diseases or organ problems such as tumors
- Psychiatric disorder or severe cognitive impairment that prevents cooperation
- Expected survival of less than 3 months
- Contrast medium allergy or severe needle phobia
- Pregnant, planning pregnancy or breastfeeding women
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07493902, who can take part
Where in China
- Xiaonong FanTianjin, ChinaContact: Xiaonong Fan, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Trial code
- NCT07493902
- Record updated
- 25 March 2026
- Original description
Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.Read full original descriptionShow less
Acupuncture Treatment for Post-Stroke Dysphagia: A Prospective, Multicenter Clinical Study of a Cohort-Based Embedded Partially Randomized Preference Trial
Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.
Inclusion: Age between 18 and 80 years old, no gender restrictions; Meets diagnostic criteria for ischemic or hemorrhagic stroke, confirmed by CT or MRI, with disease duration within one year; Meets diagnostic criteria for dysphagia, with FOIS grade 2-4; Vital signs stable, able to understand and cooperate with study procedures; ⑤ Patient or legal representative agrees to sign informed consent.
Exclusion: Dysphagia not caused by stroke, but resulting from other neurological disorders (e.g., motor neuron disease, myasthenia gravis) or organic lesions (e.g., tumors); Patients with psychiatric disorders or severe cognitive impairment who cannot cooperate with treatment; Patients with an expected survival time of less than 3 months; ④ Individuals with contrast medium allergy; Patients with severe needle phobia who cannot tolerate the procedure; ⑥ Pregnant women, those planning pregnancy, or lactating women; ⑦ Individuals who have participated in other clinical trials or received acupuncture within the past week.